In millions, except per share data) In millions, except per share data) Condensed Consolidated Balance Sheets

Increased Clariant Masterbatch cost synergy estimate to $75 million from preliminary estimate of $60 million added, "We are also benefitting from the acquisition of the Clariant Masterbatch business, which has been immediately accretive to adjusted EPS."  Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data)

This is where the MEVOPUR product line, and local availability from Taiwan, become extremely important.”  We aim to limit non-compliance risk and support safety in use by using only raw materials that have been specially tested in accordance with medical standards. The certification of this fourth MEVOPUR site provides further proof of our commitment to the healthcare industry and to helping our customers achieve their product safety requirements.”

As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. Please be aware that there are certain applications Avient’s Mevopur products have not been designed for, nor are they promoted or intended for use in: including, but not limited to long-term or permanent implants, birth control devices, or plastic surgery. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

Save and share the full eBook as a PDF for future reference. Download PDF

Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe. Technical Data Sheets Safety Data Sheets

Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe. Technical Data Sheets Safety Data Sheets

Buyer acknowledges that information in Seller’s marketing materials, technical data sheets and other descriptive publications distributed or published on its websites may vary from time to time without notice. Buyer acknowledges that Seller has furnished to Buyer safety data sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product. Confidentiality and Data Protection.

We are also benefitting from the recent acquisition of Clariant Masterbatch and early synergy capture.  Factors that could cause actual results to differ materially from those implied by these forward-looking statements include the impact the COVID-19 pandemic has on our business, results from operations, financial condition and liquidity; our ability to achieve the strategic and other objectives relating to the acquisition of Clariant's Masterbatch business, including any expected synergies; our ability to successfully integrate Clariant's Masterbatch business and achieve the expected results of the acquisition of Clariant's Masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; our ability to continue to pay cash dividends including at the increased rate; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisitions and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.

Mevopur™ Healthcare Functional Additives Laser Welding Additives for Medical Devices Laser welding has become a technology of choice to join plastic parts of complex medical devices. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com